THis week’s edition of the
Repatriation General Hospital
Pharmacy E-Bulletin gives an
overview of tapentadol, which
is currently TGA approved for
treatment of moderate-to-severe
chronic pain unresponsive to nonopioid
analgesics.
To view the bulletin CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 28 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 May 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.